Literature DB >> 22878878

Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city.

Eric Chung Ching Leung1, Chi Chiu Leung, Kai Man Kam, Wing Wai Yew, Kwok Chiu Chang, Wai Man Leung, Cheuk Ming Tam.   

Abstract

Multidrug-resistant (MDR)- tuberculosis (TB) and extensively drug resistant (XDR)-TB reportedly lead to increased household transmission. This is a retrospective cohort study of active TB occurring among household contacts exposed to MDR-TB. Of 704 contacts in 246 households, initial screening identified 12 (1.7%) TB cases (prevalent cases) and 17 (2.4%) contacts that subsequently developed active TB (secondary cases) after a median (range) duration of 17 (5-62.5) months. Eight prevalent cases and three secondary cases had MDR-TB. TB incidence rates per 100,000 person-years were 254.9 overall and 45.0 for MDR-TB. XDR-TB in the index MDR-TB patient significantly increased the odds of identifying a prevalent TB case to 4.8 (95% CI 1.02-22.5), and the hazard of finding a secondary TB case to 4.7 (95% CI 1.7-13.5). Molecular fingerprinting confirmed household transmission of MDR-TB. Of 20 retrievable isolates from 27 XDR-TB index cases, restriction fragment length polymorphism analysis showed clustering among 13 (65%), with 11 (55%) due to recent transmission by n-1 method and an identifiable household source in only three (27.2%) of the 11 cases. XDR-TB relative to MDR-TB significantly increases household transmission of TB, probably reflecting prolonged/higher infectivity, and indicating a need for prolonged household surveillance. XDR-TB may largely transmit outside of the household settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878878     DOI: 10.1183/09031936.00071212

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

Authors:  Amita Gupta; Susan Swindells; Soyeon Kim; Michael D Hughes; Linda Naini; Xingye Wu; Rodney Dawson; Vidya Mave; Jorge Sanchez; Alberto Mendoza; Pedro Gonzales; Nagalingeswaran Kumarasamy; Kyla Comins; Francesca Conradie; Justin Shenje; Sandy Nerette Fontain; Anthony Garcia-Prats; Aida Asmelash; Supalert Nedsuwan; Lerato Mohapi; Umesh G Lalloo; Ana Cristina Garcia Ferreira; Christopher Mugah; Mark Harrington; Lynne Jones; Samyra R Cox; Betsy Smith; N Sarita Shah; Anneke C Hesseling; Gavin Churchyard
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

2.  Using Cure Models to Estimate the Serial Interval of Tuberculosis With Limited Follow-up.

Authors:  Yicheng Ma; Helen E Jenkins; Paola Sebastiani; Jerrold J Ellner; Edward C Jones-López; Reynaldo Dietze; Charles R Horsburgh; Laura F White
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

Review 3.  Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  José M Porcel; Chi Chiu Leung; Marcos I Restrepo; Kazuhisa Takahashi; Pyng Lee
Journal:  Respirology       Date:  2013-04       Impact factor: 6.424

4.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

5.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

6.  The spread of drug-resistant tuberculosis in children: an Italian case series.

Authors:  F Mignone; L R Codecasa; C Scolfaro; I Raffaldi; L Lancella; M Ferrarese; S Garazzino; C Marabotto; S Esposito; C Gabiano; R Lipreri; P-A Tovo
Journal:  Epidemiol Infect       Date:  2013-12-19       Impact factor: 4.434

7.  Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis.

Authors:  Y Ma; C R Horsburgh; L F White; H E Jenkins
Journal:  Epidemiol Infect       Date:  2018-07-04       Impact factor: 4.434

8.  Estimation of the generation interval using pairwise relative transmission probabilities.

Authors:  Sarah V Leavitt; Helen E Jenkins; Paola Sebastiani; Robyn S Lee; C Robert Horsburgh; Andrew M Tibbs; Laura F White
Journal:  Biostatistics       Date:  2022-07-18       Impact factor: 5.279

9.  Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.

Authors:  Kefyalew Addis Alene; Kerri Viney; Emma S McBryde; Archie C A Clements
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

10.  Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.

Authors:  Carole D Mitnick; Molly F Franke; Michael L Rich; Felix A Alcantara Viru; Sasha C Appleton; Sidney S Atwood; Jaime N Bayona; Cesar A Bonilla; Katiuska Chalco; Hamish S F Fraser; Jennifer J Furin; Dalia Guerra; Rocio M Hurtado; Keith Joseph; Karim Llaro; Lorena Mestanza; Joia S Mukherjee; Maribel Muñoz; Eda Palacios; Epifanio Sanchez; Kwonjune J Seung; Sonya S Shin; Alexander Sloutsky; Arielle W Tolman; Mercedes C Becerra
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.